Literature DB >> 22116341

Variable selection for optimal treatment decision.

Wenbin Lu1, Hao Helen Zhang, Donglin Zeng.   

Abstract

In decision-making on optimal treatment strategies, it is of great importance to identify variables that are involved in the decision rule, i.e. those interacting with the treatment. Effective variable selection helps to improve the prediction accuracy and enhance the interpretability of the decision rule. We propose a new penalized regression framework which can simultaneously estimate the optimal treatment strategy and identify important variables. The advantages of the new approach include: (i) it does not require the estimation of the baseline mean function of the response, which greatly improves the robustness of the estimator; (ii) the convenient loss-based framework makes it easier to adopt shrinkage methods for variable selection, which greatly facilitates implementation and statistical inferences for the estimator. The new procedure can be easily implemented by existing state-of-art software packages like LARS. Theoretical properties of the new estimator are studied. Its empirical performance is evaluated using simulation studies and further illustrated with an application to an AIDS clinical trial.

Entities:  

Keywords:  A-learning; optimal treatment strategy; personalized drugs; shrinkage method; variable selection

Mesh:

Year:  2011        PMID: 22116341      PMCID: PMC3303960          DOI: 10.1177/0962280211428383

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  10 in total

1.  An experimental design for the development of adaptive treatment strategies.

Authors:  S A Murphy
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

2.  Reinforcement learning design for cancer clinical trials.

Authors:  Yufan Zhao; Michael R Kosorok; Donglin Zeng
Journal:  Stat Med       Date:  2009-11-20       Impact factor: 2.373

3.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Authors:  Min Qian; Susan A Murphy
Journal:  Ann Stat       Date:  2011-04-01       Impact factor: 4.028

4.  Variable Selection for Qualitative Interactions.

Authors:  L Gunter; J Zhu; S A Murphy
Journal:  Stat Methodol       Date:  2011-01-30

5.  A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.

Authors:  S M Hammer; D A Katzenstein; M D Hughes; H Gundacker; R T Schooley; R H Haubrich; W K Henry; M M Lederman; J P Phair; M Niu; M S Hirsch; T C Merigan
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

Review 6.  Inference for non-regular parameters in optimal dynamic treatment regimes.

Authors:  Bibhas Chakraborty; Susan Murphy; Victor Strecher
Journal:  Stat Methods Med Res       Date:  2009-07-16       Impact factor: 3.021

7.  Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach.

Authors:  Anastasios A Tsiatis; Marie Davidian; Min Zhang; Xiaomin Lu
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

8.  A generalized estimator of the attributable benefit of an optimal treatment regime.

Authors:  Jason Brinkley; Anastasios Tsiatis; Kevin J Anstrom
Journal:  Biometrics       Date:  2009-06-09       Impact factor: 2.571

9.  Stromal gene signatures in large-B-cell lymphomas.

Authors:  G Lenz; G Wright; S S Dave; W Xiao; J Powell; H Zhao; W Xu; B Tan; N Goldschmidt; J Iqbal; J Vose; M Bast; K Fu; D D Weisenburger; T C Greiner; J O Armitage; A Kyle; L May; R D Gascoyne; J M Connors; G Troen; H Holte; S Kvaloy; D Dierickx; G Verhoef; J Delabie; E B Smeland; P Jares; A Martinez; A Lopez-Guillermo; E Montserrat; E Campo; R M Braziel; T P Miller; L M Rimsza; J R Cook; B Pohlman; J Sweetenham; R R Tubbs; R I Fisher; E Hartmann; A Rosenwald; G Ott; H-K Muller-Hermelink; D Wrench; T A Lister; E S Jaffe; W H Wilson; W C Chan; L M Staudt
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245

10.  Improving efficiency of inferences in randomized clinical trials using auxiliary covariates.

Authors:  Min Zhang; Anastasios A Tsiatis; Marie Davidian
Journal:  Biometrics       Date:  2008-01-11       Impact factor: 1.701

  10 in total
  54 in total

1.  Robust regression for optimal individualized treatment rules.

Authors:  W Xiao; H H Zhang; W Lu
Journal:  Stat Med       Date:  2019-02-11       Impact factor: 2.373

2.  Semiparametric Single-Index Model for Estimating Optimal Individualized Treatment Strategy.

Authors:  Rui Song; Shikai Luo; Donglin Zeng; Hao Helen Zhang; Wenbin Lu; Zhiguo Li
Journal:  Electron J Stat       Date:  2017       Impact factor: 1.125

3.  Simple subgroup approximations to optimal treatment regimes from randomized clinical trial data.

Authors:  Jared C Foster; Jeremy M G Taylor; Niko Kaciroti; Bin Nan
Journal:  Biostatistics       Date:  2014-11-13       Impact factor: 5.899

4.  Change-Plane Analysis for Subgroup Detection and Sample Size Calculation.

Authors:  Ailin Fan; Rui Song; Wenbin Lu
Journal:  J Am Stat Assoc       Date:  2017-04-13       Impact factor: 5.033

5.  Identifying optimal biomarker combinations for treatment selection via a robust kernel method.

Authors:  Ying Huang; Youyi Fong
Journal:  Biometrics       Date:  2014-08-14       Impact factor: 2.571

6.  Estimation of treatment policies based on functional predictors.

Authors:  Ian W McKeague; Min Qian
Journal:  Stat Sin       Date:  2014-07       Impact factor: 1.261

7.  Comment.

Authors:  Min Qian
Journal:  J Am Stat Assoc       Date:  2017-01-04       Impact factor: 5.033

8.  ON ESTIMATION OF THE OPTIMAL TREATMENT REGIME WITH THE ADDITIVE HAZARDS MODEL.

Authors:  Suhyun Kang; Wenbin Lu; Jiajia Zhang
Journal:  Stat Sin       Date:  2018-07       Impact factor: 1.261

9.  Generated effect modifiers (GEM's) in randomized clinical trials.

Authors:  Eva Petkova; Thaddeus Tarpey; Zhe Su; R Todd Ogden
Journal:  Biostatistics       Date:  2016-07-27       Impact factor: 5.899

10.  A single-index model with multiple-links.

Authors:  Hyung Park; Eva Petkova; Thaddeus Tarpey; R Todd Ogden
Journal:  J Stat Plan Inference       Date:  2019-07-04       Impact factor: 1.111

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.